DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Silicon dioxide is an investigational drug.
There have been 6 clinical trials for Silicon dioxide. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2011.
The most common disease conditions in clinical trials are Renal Insufficiency, Hypersensitivity, and Dentin Sensitivity. The leading clinical trial sponsors are German Federal Ministry of Education and Research, UPECLIN HC FM Botucatu Unesp, and Omnifarma Kiev LLC.
There are one hundred and eighty-three US patents protecting this investigational drug and one international patent.
Recent Clinical Trials for Silicon dioxide
|Probiotics for Quality of Life in Autism Spectrum Disorders||Autism Speaks||Phase 0|
|Probiotics for Quality of Life in Autism Spectrum Disorders||Autism Treatment Network||Phase 0|
|Probiotics for Quality of Life in Autism Spectrum Disorders||Ohio State University||Phase 0|
Top disease conditions for Silicon dioxide
Top clinical trial sponsors for Silicon dioxide
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Silicon dioxide||See Pricing||Pesticidal polyhalo alkenoic acid esters||FMC Corporation (Philadelphia, PA)||See Pricing|
|Silicon dioxide||See Pricing||Azelastine and its salts used to combat psoriasis||Asta Pharma AG (DE)||See Pricing|
|Silicon dioxide||See Pricing||Preparation of 2,2-disubstituted pentane-1,5-diamines||BASF Aktiengesellschaft (Ludwigshafen, DE)||See Pricing|
|Silicon dioxide||See Pricing||Process for the preparation of 2-nitro-5-fluoro- or -5-chlorophenol||Hoechst Aktiengesellschaft (Frankfurt am Main, DE)||See Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Silicon dioxide||Austria||111735||2009-01-11||See Pricing|
|Silicon dioxide||Austria||113208||2009-01-11||See Pricing|
|Silicon dioxide||Australia||4786290||2009-01-11||See Pricing|
|Silicon dioxide||Australia||618443||2009-01-11||See Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|